GMED vs PHG
Globus Medical vs Koninklijke Philips N.V. — AI-powered side-by-side comparison
GMED
Globus Medical
71
Buy
VS
PHG
Koninklijke Philips N.V.
61
Buy
| Metric | GMED | PHG |
|---|
| AI Score |
71
|
61
|
| Price |
$85.12
|
$27.06
|
| P/E Ratio |
21.45×
|
20.13×
|
| ROE |
11.8%
|
8.2%
|
| Revenue Growth YoY |
—
|
—
|
| Gross Margin |
68.5%
|
45.9%
|
| Debt / Equity |
0.02×
|
0.65×
|
| Dividend Yield |
0.0%
|
3.6%
|
| RSI (14) |
75.9
|
64.1
|
| Beta |
0.954
|
0.916
|
| Expected Upside |
+0.1%
|
—
|
AI Committee View
Current Innellis committee reasoning for GMED versus PHG.
GMED leads by 10 points.
GMED scores 71/100 (Buy) versus PHG at 61/100 (Buy).
GMED Committee View
75% agreement
4 analysts
The primary driver is 5 consecutive earnings beats -- consistent execution. The main limiting factor is rsi at 76 is in overbought territory. The committee is constructive but not yet at full conviction.
Bull Case
- 5 consecutive earnings beats -- consistent execution — Growth
- Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
- MACD histogram positive -- bullish momentum — Technical
Bear Case
- RSI at 76 is in overbought territory — Technical
- Price trading above the upper Bollinger Band -- stretched — Technical
PHG Committee View
60% agreement
5 analysts
Positive signals support the current rating — vix regime is low -- calm backdrop supports risk-taking. The committee sees sufficient evidence to maintain the constructive view.
Bull Case
- Dividend yield of 4.2% pays you to wait — Value
- EPS growing 157.8% YoY — Growth
- MACD histogram positive -- bullish momentum — Technical
Bear Case
- Revenue declining -25.8% YoY -- this is not a growth story right now — Growth